Loading…
A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,649 other S bills in the 118th — cohort avg 33d
This bill requires the Centers for Medicare & Medicaid Services to issue guidance for state Medicaid programs on best practices to support individuals with major depressive disorder or other mental health conditions, including options that include pharmacogenetic testing.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2024 · fourth_quarter · Health Issues
Support for H.R. 1770 - Provider status for pharmacists Support S. 708 - Expansion of pharmacogenomic testing for individuals covered by Medicaid Support S. 114 - Allows preventive healthcare savings to be used in CBO estimates Reforms to CMS' Long-Stay Antipsychotic Quality Measure Pharmacy Benefit Manager Reform Legislation Access to Long-Term Pharmacy Services At Home Implementation of the Inflation Reduction Act
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $15,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2024 · fourth_quarter · Medicare/Medicaid
Seeking coverage of genetic testing for psychiatric precision medicine - A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions, S.708.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
Seeking coverage of genetic testing for psychiatric precision medicine - A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions, S.708.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Medicare/Medicaid
S.708 - legislation to require a dear Medicaid director letter concerning precision medicine for depression. Regulations governing Medicare Advantage plans and the use of prior authorization.
Client expense: $290,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
Support for H.R. 1770 - Provider status for pharmacists Support S. 708 - Expansion of pharmacogenomic testing for individuals covered by Medicaid Support S. 114 - Allows preventive healthcare savings to be used in CBO estimates Reforms to CMS' Long-Stay Antipsychotic Quality Measure Pharmacy Benefit Manager Reform Legislation Cybersecurity attack on Change Healthcare Access to Long-Term Pharmacy Services At Home Implementation of the Inflation Reduction Act
Client expense: $15,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2024 · third_quarter · Medicare/Medicaid
Seeking coverage of genetic testing for psychiatric precision medicine - A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions, S.708.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
Seeking coverage of genetic testing for psychiatric precision medicine - A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions, S.708.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Medicare/Medicaid
S.708 - legislation to require CMS to issue a dear Medicaid director letter concerning precision medicine for depression. Regulations governing Medicare Advantage plans and the use of prior authorization.
Client expense: $290,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
Support for H.R. 1770 - Provider status for pharmacists Support S. 708 - Expansion of pharmacogenomic testing for individuals covered by Medicaid Support S. 114 - Allows preventive healthcare savings to be used in CBO estimates Reforms to CMS' Long-Stay Antipsychotic Quality Measure Pharmacy Benefit Manager Reform Legislation Cybersecurity attack on Change Healthcare Access to Long-Term Pharmacy Services At Home
Client expense: $15,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2024 · second_quarter · Medicare/Medicaid
S708 - legislation to require CMS to issue a dear Medicaid director letter concerning precision medicine for depression Regulations governing Medicare Advantage plans and the use of prior authorization
Client expense: $290,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Medicare/Medicaid
Seeking coverage of genetic testing for psychiatric precision medicine - A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions, S.708.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
Seeking coverage of genetic testing for psychiatric precision medicine - A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions, S.708.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Medicare/Medicaid
S708 - legislation to require CMS to issue a dear Medicaid director letter concerning precision medicine for depression Regulations governing Medicare Advantage plans and the use of prior authorization
Client expense: $290,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Medicare/Medicaid
Seeking coverage of genetic testing for psychiatric precision medicine - A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions, S.708.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
Seeking coverage of genetic testing for psychiatric precision medicine - A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions, S.708.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
Support for H.R. 1770 - Provider status for pharmacists Support S. 708 - Expansion of pharmacogenomic testing for individuals covered by Medicaid Support S. 114 - Allows preventive healthcare savings to be used in CBO estimates Reforms to CMS' Long-Stay Antipsychotic Quality Measure Pharmacy Benefit Manager Reform Legislation Cybersecurity attack on Change Healthcare Access to Long-Term Pharmacy Services At Home
Client expense: $15,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2023 · fourth_quarter · Health Issues
Support for H.R. 1770 - Provider status for pharmacists Support S. 708 - Expansion of pharmacogenomic testing for individuals covered by Medicaid Support S. 114 - Allows preventive healthcare savings to be used in CBO estimates Reforms to CMS' Long-Stay Antipsychotic Quality Measure Access to Long-Term Pharmacy Services At Home
Client expense: $15,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2023 · fourth_quarter · Medicare/Medicaid
S708 - legislation to require CMS to issue a dear Medicaid director letter concerning precision medicine for depression Regulations governing Medicare Advantage plans and the use of prior authorization
Client expense: $290,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Health Issues
Seeking coverage of genetic testing for psychiatric precision medicine - A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions, S.708.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Medicare/Medicaid
Seeking coverage of genetic testing for psychiatric precision medicine - A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions, S.708.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Health Issues
Support for H.R. 1770 - Provider status for pharmacists Support S. 708 - Expansion of pharmacogenomic testing for individuals covered by Medicaid Support S. 114 - Allows preventive healthcare savings to be used in CBO estimates Reforms to CMS' Long-Stay Antipsychotic Quality Measure Access to Long-Term Pharmacy Services At Home
Client expense: $15,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2023 · third_quarter · Medicare/Medicaid
S708 - legislation to require CMS to issue a dear Medicaid director letter concerning precision medicine for depression
Client expense: $210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Medicare/Medicaid
Seeking coverage of genetic testing for psychiatric precision medicine - A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions, S.708.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Health Issues
Seeking coverage of genetic testing for psychiatric precision medicine - A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions, S.708.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Health Issues
Viral sequencing derived from blood and spital, viral surveillance and COVID-19 not limited to issues in US H1425 Senate Ratification of Pandemic World Health Organization Agreements, planning for FY24 budget, and Pandemic All Hazards Preparedness Reauthorization. Issues related to biomarker testing, hereditary cancers, and pharmacogenomics including US S708 Medicaid Coverage for Major Depressive Disorders.
Client expense: $120,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2023 · second_quarter · Health Issues
Seeking coverage of genetic testing for psychiatric precision medicine-S.708
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Medicare/Medicaid
S708 - legislation to require CMS to issue a dear Medicaid director letter concerning precision medicine for depression H.R. 4531, the Support for Patients and Communities Reauthorization Act
Client expense: $210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Health Issues
Support for H.R. 1770 - Provider status for pharmacists Support S. 708 - Expansion of pharmacogenomic testing for individuals covered by Medicaid Support S. 114 - Allows preventive healthcare savings to be used in CBO estimates Reforms to CMS' Long-Stay Antipsychotic Quality Measure Preservation of 1135 waivers related to COVID-19 public health emergency
Client expense: $15,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2023 · first_quarter · Health Issues
Support for H.R. 1770 - Provider status for pharmacists Support S. 708 - Expansion of pharmacogenomic testing for individuals covered by Medicaid Support S. 114 - Allows preventive healthcare savings to be used in CBO estimates Removes to CMS' Long-Stay Antipsychotic Quality Measure Access to Medication for aggression associated with Alzheimer's Disease Preservation of 1135 waivers related to COVID-19 public health emergency
Client expense: $15,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2023 · first_quarter · Medicare/Medicaid
S708 - legislation to require CMS to issue a dear medicaid director letter concerning precision medicine for depression Legislation not introduced related to in person visits for high-cost lab tests ordered in Medicare
Client expense: $390,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE